These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2833914)

  • 21. Humoral effects of ACE-inhibition.
    Cerasola G; Cottone S; Grasso L; D'Ignoto G; Carone MB; Carapelle E; Fulantelli MA; Contorno A
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):195-200. PubMed ID: 2820442
    [No Abstract]   [Full Text] [Related]  

  • 22. Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects.
    Ayers CR; Baker KM; Weaver BA; Lehman MR
    Drugs; 1985; 30 Suppl 1():70-3. PubMed ID: 2994989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
    Wing LM; Chalmers JP; West MJ; Russell AE; Morris MJ; Cain MD; Bune AJ; Southgate DO
    Clin Exp Hypertens A; 1988; 10(1):119-33. PubMed ID: 2832102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the acetylcholinesterase inhibitors enalapril and captopril on exercise tolerance in hypertensive patients].
    Lai C; Onnis E; Pirisi R; Orani E; Soro A; Cherchi A
    Cardiologia; 1988 Feb; 33(2):211-5. PubMed ID: 2834061
    [No Abstract]   [Full Text] [Related]  

  • 29. Captopril in the treatment of essential hypertension.
    Vas A; Gachályi B; Nádas B; Csillag K; Káldor A
    Ther Hung; 1988; 36(1):11-5. PubMed ID: 2838921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical monitoring of vasoactive peptides during angiotensin converting enzyme inhibition.
    Giese J; Rasmussen S; Nielsen MD; Ibsen H
    J Hypertens Suppl; 1983 Oct; 1(1):31-6. PubMed ID: 6100607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of once-daily captopril or enalapril in mild essential hypertension.
    Pixley JS; Marshall MK; Stanley H; Starich GH; Ferguson RK
    J Clin Pharmacol; 1989 Feb; 29(2):118-22. PubMed ID: 2541177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Captopril in the treatment of hypertension (author's transl)].
    Favre L
    Schweiz Rundsch Med Prax; 1981 Aug; 70(35):1487-90. PubMed ID: 7024978
    [No Abstract]   [Full Text] [Related]  

  • 36. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
    [No Abstract]   [Full Text] [Related]  

  • 37. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.
    Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
    Overlack A; Stumpe KO; Kühnert M; Heck I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.